Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 3

2(28.6%)

Phase 1

2(28.6%)

Phase 4

1(14.3%)

Phase 2

1(14.3%)

N/A

1(14.3%)

7Total

Phase 3(2)

Phase 1(2)

Phase 4(1)

Phase 2(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04547816Phase 3Recruiting

Efficacy of Conservative Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse

Role: collaborator

NCT05432960Phase 3Withdrawn

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

Role: collaborator

NCT05550792Not ApplicableCompleted

Cardiac Contractility Modulation in Patients With Chronic Heart Failure and the Various Forms of Atrial Fibrillation

Role: collaborator

NCT03753087Phase 4Completed

Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus

Role: collaborator

NCT01511419Phase 1Completed

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Role: collaborator

NCT02997280Phase 2Completed

Ruxolitinib for Steroid-refractory GVHD

Role: collaborator

NCT01982331Phase 1Completed

Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine

Role: collaborator

NCT02793934Unknown

The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation

Role: collaborator

All 8 trials loaded